EDWARDS SYSTEMS TECHNOLOGYBusiness Directories,Company Directories

Company Name: Corporate Name:	EDWARDS SYSTEMS TECHNOLOGY
Company Title:
Company Description:
Keywords to Search:
Company Address:	18124 102 Ave NW,EDMONTON,AB,Canada
ZIP Code: Postal Code:	T5S1S7
Telephone Number:	7804526609
Fax Number:	7804538097
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	506308
USA SIC Description:	Fire Alarm Systems (Wholesale)
Number of Employees:	20 to 49
Sales Amount:	$10 to 20 million
Credit History: Credit Report:	Excellent
Contact Person:	Matt Gross
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
EDWARDS, GAIL L
EDWARDS, DAVID C MD
EDWARDS, D MD

Next company profile:
EDWARDS SAWATZKY BEVERLY DR PSYC
EDWARDS SECURITY
EDWARDS DAVID C DR SURG MEADOWLARK HEAL

Company News:

Edwards Lifesciences - the leader in heart valves hemodynamic . . .
Learn about early detection, management of conditions, and various treatment options
Edwards Lifesciences Reports Second Quarter Results
IRVINE, Calif --(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2025 Recent Highlights Q2 sales grew 11 9% to $1 53 billion, or 10 6% adjusted 1, with strength across all product groups; Q2 TAVR sales grew 8 9%; constant currency 1 sales grew 7 8%; Q2 TMTT sales reached $134 5 million or $133 0 million adjusted 1, driven by
Contact Us - Edwards Lifesciences
Discover all of our products and services designed to fit your needs
Internship Program | Edwards Lifesciences
At Edwards, our Summer Internship Program provides aspiring leaders of the medical device industry with a valuable opportunity to contribute to our mission of improving patient care
Search Jobs - Edwards Lifesciences
Edwards Lifesciences is an equal opportunity employer We believe that diversity and inclusion are essential to creating an environment where all our employees can grow and thrive
Sapien M3 | Edwards Lifesciences
Trial objective Establish the safety and effectiveness of the SAPIEN M3 system in subjects with symptomatic, at least 3+ MR for whom commercially available surgical or transcatheter treatment options are deemed unsuitable due to clinical, anatomical, or technical considerations
TruWave Pressure Transducers | Edwards Lifesciences
Accuracy for your patients Our standard TruWave pressure monitoring transducer kits are sterile, single-use kits that relay blood pressure information from a pressure monitoring catheter to a patient monitoring system
Global Locations - Edwards Lifesciences
Learn about early detection, management of conditions, and various treatment options
Our leaders - Edwards Lifesciences
Bernard J Zovighian is CEO and on the Board of Directors of Edwards Lifesciences since May 2023, after serving as the company’s president As CEO, Zovighian is leading Edwards into a new era of groundbreaking structural heart innovation, with a sharpened focus and pursuit of expanded opportunities to transform the care of structural heart patients worldwide
Edwards Lifesciences Corp - Edwards SAPIEN M3 Receives CE Mark . . .
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy Leveraging the company’s SAPIEN technology, the SAPIEN M3